510-511 / 2351
Suggested literature
•
Overgaard, J. et al. Five compared with six fractions per week of conventional radiotherapy of squamous‐cell
carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial The Lancet 362: 933‐940 2003
.
,
.
•
Bourhis J et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta‐analysis. Lancet
2006; 368: 843–54.
•
Overgaard J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A
systematic review and meta analysis Radiother Oncol (2011)
‐
.
•
Nordsmark et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation
therapy. An international multi‐center study. Radiotherapy and Oncology 77 (2005) 18–24
•
Bernier J, Licitra L. Chemoradiation in head‐and‐neck cancer—are we any closer? Nature reviews | clinical
oncology volume 7 May 2010
,
•
Pignon JP et al. Chemotherapy added to locoregional treatment for head and neck squamous‐cell carcinoma:
three meta‐analyses of updated individual data. Lancet 2000;355:949‐55.
•
Pignon JP et al. Meta‐analysis of chemotherapy in head and neck cancer (MACH‐NC): An update on 93 randomised
t i l
d 17 346 ti t R di th
d O l
92 (2009) 4 14
r a s an ,
pa en s. a o erapy an nco ogy
–
•
Budach W. et al. A meta‐analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy
and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC
Cancer 2006, 6:28
B i J
l P
i
I di i
i h i h C
i
Ch h f L ll Ad d H d
•
ern er et. a . ostoperat ve rra at on w t or w t out oncom tant emot erapy or oca y vance ea
and Neck Cancer. N Engl J Med 350;19, 2004
•
Cooper JS et al. Postoperative concurrent radiotherapy and chemotherapy for high‐risk squamous‐cell carcinoma
of the head and neck. N Engl J Med 2004;350:1937‐44.
•
Bonner JA et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5‐year survival
data from a phase 3 randomised trial, and relation between cetuximab‐induced rash and survival. Lancet Oncol
2010; 11: 21–28